SCHEMBL10072095

SCHEMBL10072095

CCCC(=O)/C=C/c1ccc(C=O)cn1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IAPP P10997 5/20 0.53
RAB9A P51151 4/20 0.41
ALDH1A1 P00352 4/20 0.41
NPC1 O15118 3/20 0.41
KDM4E B2RXH2 3/20 0.41
APP P05067 1/20 0.41
HTT P42858 1/20 0.41
KMT2A Q03164 1/20 0.40
TOP2A P11388 1/20 0.38
HDAC3 O15379 1/20 0.38
HDAC4 P56524 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC7 Q8WUI4 1/20 0.38
HDAC2 Q92769 1/20 0.38
HDAC10 Q969S8 1/20 0.38
HDAC11 Q96DB2 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
HDAC9 Q9UKV0 1/20 0.38
HDAC5 Q9UQL6 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19680073 0.81 IAPP (0.45) IAPPRAB9AALDH1A1NPC1KDM4E
SCHEMBL9944607 0.80 MAPT (0.46) IAPPALDH1A1KDM4EAPPHTT
SCHEMBL1481958 0.78 P4HTM (0.54) RAB9AALDH1A1KDM4EAPPKMT2A
SCHEMBL1481960 0.78 P4HTM (0.54) RAB9AALDH1A1KDM4EAPPKMT2A
SCHEMBL1704850 0.77 CA12 (0.56) RAB9AALDH1A1NPC1KDM4EAPP
SCHEMBL1704853 0.77 CA12 (0.56) RAB9AALDH1A1NPC1KDM4EAPP
SCHEMBL13928028 0.73 HDAC8 (0.42) ALDH1A1KDM4EAPPKMT2AHDAC3
SCHEMBL1320223 0.73 ESR1 (0.37) ALDH1A1KDM4EHTTKMT2AHDAC3
SCHEMBL1320221 0.73 ESR1 (0.37) ALDH1A1KDM4EHTTKMT2AHDAC3
SCHEMBL22811244 0.72 MAPT (0.44) ALDH1A1KDM4EHTTL3MBTL1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012025701-A1 ALPHA, ALPHA - DI SUBSTITUTED GLYCINE ESTER DERIVATIVES AND THEIR USE AS HDAC INHIBITORS CHROMA THERAPEUTICS LTD. (GB) 2012-03-01 WO disclosed